Slower processing speed after treatment for pediatric brain tumor and acute lymphoblastic leukemia - PubMed (original) (raw)
. 2013 Sep;22(9):1979-86.
doi: 10.1002/pon.3255. Epub 2013 Feb 28.
Affiliations
- PMID: 23447439
- PMCID: PMC3740073
- DOI: 10.1002/pon.3255
Slower processing speed after treatment for pediatric brain tumor and acute lymphoblastic leukemia
Lisa S Kahalley et al. Psychooncology. 2013 Sep.
Abstract
Background: Acute lymphoblastic leukemia (ALL) and brain tumor (BT) survivors are at risk for post-treatment IQ declines. The extent to which lower scores represent global cognitive decline versus domain-specific impairment remains unclear. This study examined discrepancies between processing speed and estimated IQ (EIQ) scores and identified clinical characteristics associated with score discrepancies in a sample of pediatric cancer survivors.
Procedure: Survivors (50 ALL, 50 BT) ages 12-17 years completed cognitive testing. The Wechsler Abbreviated Scale of Intelligence provided an untimed measure of general reasoning ability (EIQ). The age-appropriate Wechsler Intelligence Scale provided a Processing Speed Index (PSI) score. Scores were examined and compared.
Results: Survivors' PSI scores were lower than their EIQ scores (BT t(45) =6.3, p<0.001; ALL t(49) =6.9, p<0.001). For BT survivors, lower PSI scores were associated with history of craniospinal irradiation, t(44) =3.3, p<0.01. For ALL survivors, lower PSI scores were associated with male gender, grade retention, and time since diagnosis, F(3, 46) =10.1, p<0.001. Clinically significant EIQ-PSI score discrepancies were identified in 41.3% of BT and 14.0% of ALL survivors.
Conclusions: Many pediatric BT and ALL survivors exhibit slower processing speed than expected for age, whereas general reasoning ability remains largely intact. Risk factors associated with larger EIQ-PSI discrepancies include the following: BT diagnosis, craniospinal irradiation (BT only), male gender, and younger age at diagnosis (ALL only). Grade retention was frequent and associated with lower EIQ scores (both groups) and PSI scores (ALL only). Describing post-treatment cognitive declines using global measures of intellectual ability may underestimate dysfunction or fail to isolate specific underlying deficits contributing to impairment.
Keywords: intelligence; late effects of cancer treatment; pediatric hematology/oncology; processing speed.
Copyright © 2013 John Wiley & Sons, Ltd.
Conflict of interest statement
Conflict of Interest Statement: None to declare.
Figures
Figure 1
Frequency distribution of PSI and EIQ scores for BT survivors (n = 46). Scores < 77.5 are considered clinically significant. PSI = Processing Speed Index. EIQ = Estimated IQ.
Figure 2
Frequency distribution of PSI and EIQ scores for ALL survivors (n = 50). Scores < 77.5 are considered clinically significant. PSI = Processing Speed Index. EIQ = Estimated IQ.
Figure 3
Frequency distributions of EIQ-PSI difference scores by diagnostic group (BT n = 46, ALL n = 50). Difference scores > 22.5 are considered clinically significant. EIQ = Estimated IQ. PSI = Processing Speed Index.
Similar articles
- Utility of the General Ability Index (GAI) and Cognitive Proficiency Index (CPI) with survivors of pediatric brain tumors: Comparison to Full Scale IQ and premorbid IQ estimates.
Kahalley LS, Winter-Greenberg A, Stancel H, Ris MD, Gragert M. Kahalley LS, et al. J Clin Exp Neuropsychol. 2016 Dec;38(10):1065-76. doi: 10.1080/13803395.2016.1189883. Epub 2016 Jun 13. J Clin Exp Neuropsychol. 2016. PMID: 27295192 Free PMC article. - Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemia.
Winter AL, Conklin HM, Tyc VL, Stancel H, Hinds PS, Hudson MM, Kahalley LS. Winter AL, et al. J Clin Exp Neuropsychol. 2014;36(8):818-30. doi: 10.1080/13803395.2014.943695. Epub 2014 Aug 15. J Clin Exp Neuropsychol. 2014. PMID: 25126830 Free PMC article. - Computerized Cognitive Training for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors: A Randomized Controlled Trial.
Conklin HM, Ogg RJ, Ashford JM, Scoggins MA, Zou P, Clark KN, Martin-Elbahesh K, Hardy KK, Merchant TE, Jeha S, Huang L, Zhang H. Conklin HM, et al. J Clin Oncol. 2015 Nov 20;33(33):3894-902. doi: 10.1200/JCO.2015.61.6672. Epub 2015 Oct 12. J Clin Oncol. 2015. PMID: 26460306 Free PMC article. Clinical Trial. - Neurocognitive late effects in pediatric cancer.
Mulhern RK, Palmer SL. Mulhern RK, et al. Curr Probl Cancer. 2003 Jul-Aug;27(4):177-97. doi: 10.1016/s0147-0272(03)00026-6. Curr Probl Cancer. 2003. PMID: 12855950 Review. No abstract available. - Late neurocognitive sequelae in survivors of brain tumours in childhood.
Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Mulhern RK, et al. Lancet Oncol. 2004 Jul;5(7):399-408. doi: 10.1016/S1470-2045(04)01507-4. Lancet Oncol. 2004. PMID: 15231246 Review.
Cited by
- Neurocognitive and Psychosocial Outcomes in Pediatric Brain Tumor Survivors.
Stavinoha PL, Askins MA, Powell SK, Pillay Smiley N, Robert RS. Stavinoha PL, et al. Bioengineering (Basel). 2018 Sep 11;5(3):73. doi: 10.3390/bioengineering5030073. Bioengineering (Basel). 2018. PMID: 30208602 Free PMC article. Review. - Cognition and Brain System Segregation in Pediatric Brain Tumor Patients Treated with Proton Therapy.
Dowling AV, Seitzman BA, Mitchell TJ, Olufawo M, Dierker DL, Anandarajah H, Dworetsky A, McMichael A, Jiang C, Barbour DL, Schlaggar BL, Limbrick DD, Strahle JM, Rubin JB, Shimony JS, Perkins SM. Dowling AV, et al. Int J Part Ther. 2023 Jul 24;10(1):32-42. doi: 10.14338/IJPT-22-00039.1. eCollection 2023 Summer. Int J Part Ther. 2023. PMID: 37823016 Free PMC article. - Processing speed in children treated for brain tumors: effects of radiation therapy and age.
Jacobson LA, Mahone EM, Yeates KO, Ris MD. Jacobson LA, et al. Child Neuropsychol. 2019 Feb;25(2):217-231. doi: 10.1080/09297049.2018.1456517. Epub 2018 Apr 6. Child Neuropsychol. 2019. PMID: 29621934 Free PMC article. - Cognitive Sparing in Proton versus Photon Radiotherapy for Pediatric Brain Tumor Is Associated with White Matter Integrity: An Exploratory Study.
Mash LE, Kahalley LS, Raghubar KP, Goodrich-Hunsaker NJ, Abildskov TJ, De Leon LA, MacLeod M, Stancel H, Parsons K, Biekman B, Desai NK, Grosshans DR, Paulino AC, Chu ZD, Whitehead WE, Okcu MF, Chintagumpala M, Wilde EA. Mash LE, et al. Cancers (Basel). 2023 Mar 19;15(6):1844. doi: 10.3390/cancers15061844. Cancers (Basel). 2023. PMID: 36980730 Free PMC article. - Attention-mediated neurocognitive profiles in survivors of pediatric brain tumors: comparison to children with neurodevelopmental ADHD.
Hardy KK, Willard VW, Gioia A, Sharkey C, Walsh KS. Hardy KK, et al. Neuro Oncol. 2018 Apr 9;20(5):705-715. doi: 10.1093/neuonc/nox174. Neuro Oncol. 2018. PMID: 29016979 Free PMC article.
References
- Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2004. Bethesda, MD: National Cancer Institute; 2007.
- Fossen A, Abrahamsen TG, Storm-Mathisen I. Psychological outcome in children treated for brain tumor. Pediatr Hematol Oncol. 1998;15:479–488. - PubMed
- Holmquist LA, Scott J. Treatment, age, and time-related predictors of behavioral outcome in pediatric brain tumor survivors. Journal of Clinical Psychology in Medical Settings. 2002;9:315–321.
- Langer T, Martus P, Ottensmeier H, Hertzberg H, Beck JD, Meier W. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol. 2002;38:320–328. - PubMed
- Lockwood KA, Bell TS, Colegrove RW. Long-term effects of cranial radiation therapy on attention functioning in survivors of childhood leukemia. Journal of Pediatric Psychology. 1999;24:55–66.
Publication types
MeSH terms
Substances
Grants and funding
- R25 CA023944/CA/NCI NIH HHS/United States
- K07 CA157923/CA/NCI NIH HHS/United States
- F32 DA024503/DA/NIDA NIH HHS/United States
- CA21765/CA/NCI NIH HHS/United States
- P30 CA021765/CA/NCI NIH HHS/United States
- F32DA024503/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous